Evidence map›Paper›PMID 42516298›Full record

ArticleFrontiers in cell and developmental biology2026

Clonal evolution and stromal crosstalk drive an invasive epithelial program in bladder cancer.

Yongxiang Luo, Xiaoping Liu, Sihua Zhu, Peibin Lin, Jun Li, Jinjie You, Ziying Chen, Zhanfang Kang, Jianwen Zeng

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yongxiang LuoThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Xiaoping LiuThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Sihua ZhuThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Peibin LinThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Jun LiThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Jinjie YouThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Ziying ChenThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Zhanfang KangThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Jianwen ZengThe Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor progression and metastasis in bladder cancer are driven by epithelial cell heterogeneity and dynamic interactions with the tumor microenvironment. To elucidate epithelial subpopulations associated with cancer progression, we performed single-cell transcriptomic profiling of bladder cancer tissues and identified a distinct epithelial subset, termed Meta-program 6 (MP6), that was significantly enriched in samples exhibiting lymphovascular invasion or lymph node metastasis. The MP6 gene signature correlated strongly with advanced tumor stage, lymph node involvement, and lymphovascular infiltration. CNV analysis revealed extensive chromosomal alterations, particularly chromosome 19 deletion, indicating genomic instability. Cell-cell communication analysis demonstrated active crosstalk between MP6 tumor cells and cancer-associated fibroblasts, including WNT and BMP signaling pathways, indicating that stromal crosstalk may contribute to the establishment of a pro-tumorigenic microenvironment. Transcription factor network inference further identified elevated activity of regulators such as TFCP2 and ELF1, implicating them in the acquisition of aggressive phenotypes. Immunohistochemical validation supported the clinical relevance of selected MP6-associated targets. Collectively, these findings define a clonally evolved epithelial subtype associated with lymphatic invasion and provide mechanistic insights into tumor cell plasticity and stromal-epithelial interactions underlying bladder cancer progression.

Indexed as

bladder cancerclonal evolutionepithelial programsingle-cell RNA sequencingtumor heterogeneity

Identifiers

PMID42516298
PMCPMC13402393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.